Published price vs quote-only
Directmeds vs Embody: Which One Publishes Its Price? (2026)
Compare Directmeds and Embody on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.8 and 7.6 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both Directmeds and Embody will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
Embody publishes what it charges — Semaglutide $69/mo (was $299), tirzepatide $119/mo. Directmeds does not: standard post-promotional pricing is not disclosed upfront. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Easier to price in advance
- Embody — Semaglutide $69/mo (was $299), tirzepatide $119/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Embody — 24/7 support for dosing and side-effect questions.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Most support included
- Embody — 24/7 support for dosing and side-effect questions.
Side-by-side comparison
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Directmeds | Embody | |
|---|---|---|
| Advertised price | 50% off the first month | Semaglutide $69/mo (was $299), tirzepatide $119/mo |
| Rate after promotions | not published before intake | $69/mo |
| Pricing structure | Quoted only after intake | Published rate per medication |
| Medication | GLP-1 medication via licensed telehealth prescribing | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| State coverage | Nationwide | Not published |
| How fast you start | Online intake | Licensed provider review handled entirely online |
| Membership fee | Not stated | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 3,400 | 11,250 |
| eRxDoctor score | 7.8/10 | 7.6/10 |
What Directmeds and Embody actually cost over a year
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. Here is what each one costs across a realistic course of treatment, on published pricing.
| Directmeds | Embody | |
|---|---|---|
| First month | Not published | $69 |
| Months 2 onward | Not published | $69/mo |
| 6-month total | Not computable | $414 |
| 12-month total | Not computable | $828 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Directmeds: standard post-promotional pricing is not disclosed upfront. Treat any comparison that quotes one as an estimate someone else has made for you.
One publishes a price. One does not.
Embody states its terms upfront: Semaglutide $69/mo (was $299), tirzepatide $119/mo, published rate per medication. You can decide whether it fits your budget without giving anyone a medical history.
Directmeds inverts that: standard post-promotional pricing is not disclosed upfront. Personalization is a real justification, but the result is a quote delivered at the point you have already invested time in the process.
If you do go through Directmeds's intake, ask for the month-two price in writing before you pay for month one. That single question resolves most of the disclosure gap.
Inside the Directmeds program
Directmeds is a licensed telehealth platform offering GLP-1 medications with a 50% first-month discount and nationwide shipping.
The process is online intake, then nationwide shipping, no insurance required. On money, expect quoted only after intake — quote only, after intake.
Support: licensed telehealth prescribing. The medications on offer are GLP-1 medication via licensed telehealth prescribing.
Directmeds pros
- Nationwide shipping, no insurance required
- 50% off first month for new patients
- Licensed telehealth prescribing model
Directmeds cons
- Standard (post-promo) pricing is not clearly disclosed upfront
Read next to Embody, the weak point: a discount off an undisclosed price is not a price.
A closer look at Embody
Embody positions itself on the lowest published semaglutide price on this list, with no lock-in. Semaglutide $69/mo (was $299), Tirzepatide $119/mo
Getting started means licensed provider review handled entirely online, after which free shipping, 1-2 day delivery after approval. Pricing runs on a published rate per medication basis, published upfront.
Ongoing care is 24/7 support for dosing and side-effect questions, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Embody pros
- Licensed provider review handled entirely online
- 24/7 support access for dosing and side-effect questions
- Lowest entry price on this list at $69/month for compounded semaglutide
- Compounded tirzepatide available at $119/month
Embody cons
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- $69 semaglutide pricing is a limited-time offer that may increase
The reservation worth holding, particularly next to Directmeds: a limited-time rate with few of the extras that higher-priced platforms bundle.
Which one fits which patient
Choose Directmeds if:
- the level of clinical contact suits you: licensed telehealth prescribing
- you would get real value from a half-price first month and nationwide shipping with no insurance step
- delivery works the way you want it to: nationwide shipping, no insurance required
- you want to start on their timeline: online intake
Choose Embody if:
- delivery works the way you want it to: free shipping, 1-2 day delivery after approval
- you want to start on their timeline: licensed provider review handled entirely online
- you want the full price in front of you before completing an intake
- you want tirzepatide available without changing provider later
The trade-offs, stated plainly
On price. Only Embody publishes a rate you can plan against (Semaglutide $69/mo (was $299), tirzepatide $119/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On predictability. Quoted only after intake versus published rate per medication. Whichever you pick, get the maintenance-dose price in writing at intake.
On access. Directmeds advertises online intake and nationwide shipping, no insurance required; Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval. Coverage differs too — nationwide against not published — which decides the question before price does if you are in a restricted state.
The clinical evidence, separated from the marketing
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
Directmeds vs Embody: common questions
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which has more patient reviews, Directmeds or Embody?
Embody, with 11,250 against 3,400. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Directmeds or Embody take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with Directmeds compared with Embody?
Directmeds advertises online intake, with nationwide shipping, no insurance required. Embody advertises licensed provider review handled entirely online, with free shipping, 1-2 day delivery after approval. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Does Directmeds or Embody offer tirzepatide?
Embody does, at $119/mo. Directmeds publishes GLP-1 medication via licensed telehealth prescribing only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Directmeds and Embody prescribe the same medication?
Both dispense compounded GLP-1 preparations. Directmeds lists GLP-1 medication via licensed telehealth prescribing and Embody lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Directmeds leads on a half-price first month and nationwide shipping with no insurance step; Embody leads on the lowest published semaglutide price on this list, with no lock-in.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Directmeds vs RefillsPublished price vs quote-only
- Directmeds vs WellorithmHead to head
- Embody vs TMatesBudget vs premium
- Embody vs Elevate HealthBudget vs premium
- Shed vs TrimRxPublished price vs quote-only
- Shed vs Yucca HealthPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Directmeds or Embody, and does not sell treatment. Read our ranking methodology.